cheaptrix/billsum-US_congress_and_house huggingface dataset:
Access to Critical Non-Emergency Transportation Services Act

To require the Secretary of Health and Human Services, in coordination with single State agencies, to assist certain dual eligible individuals participating in the RSNAT model with accessing non-emergency medical assistance benefits under the Medicaid program, and for other purposes. 1. Short title This Act may be cited as the Access to Critical Non-Emergency Transportation Services Act 2. Assistance in accessing non-emergency medical assistance benefits under the Medicaid program (a) In general Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services (in this section referred to as the Secretary (1) in the case of a full-benefit dual eligible individual participating in the repetitive non-emergent ambulance transport model (as described in section 1834(l)(16) of such Act ( 42 U.S.C. 1395m(l)(16) 42 U.S.C. 1396a(a)(4) (2) in the case of a dual eligible individual who is not a full-benefit dual eligible individual and is participating in the repetitive non-emergent ambulance transport model (as described in section 1834(l)(16) of such Act ( 42 U.S.C. 1395m(l)(16) 42 U.S.C. 1396a(a)(4) (b) Guidance For purposes of carrying out the assistance described under subsection (a), not later than 90 days after the date of enactment of this Act the Secretary shall issue guidance to each single State agency and Medicare administrative contractor on providing assistance to dual eligible individuals participating in the repetitive non-emergent ambulance transport model (as described in section 1834(l)(16) of the Social Security Act ( 42 U.S.C. 1395m(l)(16) 42 U.S.C. 1396a(a)(4) (c) Definitions In this Act: (1) Dual eligible individual The term dual eligible individual 42 U.S.C. 1396n(h)(2)(B) (2) Full-benefit dual eligible individual The term full-benefit dual eligible individual 42 U.S.C. 1396u–5(c)(6) (3) Medicare administrative contractor The term Medicare administrative contractor 42 U.S.C. 1395kk–1(a)(3) (4) Single State agency The term single State agency 42 U.S.C. 1396a(a)(5)

Summary: Access to Critical Non-Emergency Transportation Services Act This bill requires the Centers for Medicare & Medicaid Services to work with state Medicaid programs to assist individuals who are dually eligible for Medicare and Medicaid with accessing non-emergency transportation benefits under Medicaid. The bill applies to dually eligible individuals who are participating in the Repetitive, Scheduled Non-Emergent Ambulance Transport Prior Authorization Model under Medicare.
Employee Business Expense Deduction Reinstatement Act of 2022

To amend the Internal Revenue Code of 1986 to allow unreimbursed employee expenses to be taken into account as miscellaneous itemized deductions. 1. Short title This Act may be cited as the Employee Business Expense Deduction Reinstatement Act of 2022 2. Unreimbursed employee expenses taken into account as miscellaneous itemized deduction (a) In general Section 67(g) Notwithstanding the preceding sentence for any such taxable year, an individual may take into account under subsection (a) 85 percent of any miscellaneous itemized deductions for the taxable year which are unreimbursed expenses paid or incurred by the individual in connection with the performance of services as an employee. (b) Effective date The amendment made by this section shall take effect as if included in section 11045 of Public Law 115–97 (c) Extension of statute of limitation on credit or refund If the period of limitation on a credit or refund resulting from the amendments made by subsection (a) expires before the end of the 1-year period beginning on the date of the enactment of this Act, refund or credit of such overpayment (to the extent attributable to such amendments) may, nevertheless, be made or allowed if claim therefor is filed before the close of such 1-year period.

Summary: Employee Business Expense Deduction Reinstatement Act of 2022 This bill allows an individual taxpayer to take into account 85% of any miscellaneous itemized deductions for the taxable year that are unreimbursed expenses paid or incurred by the individual in connection with the performance of services as an employee.
Stop Delta Tunnels Act

To prohibit the Corps of Engineers from issuing a permit for the Delta Conveyance Project, and for other purposes. 1. Short title This Act may be cited as the Stop Delta Tunnels Act 2. Prohibition on Delta Conveyance Project permit The Secretary of the Army, acting through the Chief of Engineers, may not issue a permit under section 404 of the Federal Water Pollution Control Act ( 33 U.S.C. 1344 Notice of Preparation of Environmental Impact Report for the Delta Conveyance Project

Summary: Stop Delta Tunnels Act This bill prohibits the U.S. Army Corps of Engineers from issuing a permit to discharge dredged or fill material into navigable waters for the proposed Delta Conveyance Project in California. The California Department of Water Resources proposed this project, which involves constructing new State Water Project diversion and conveyance facilities in the Sacramento-San Joaquin Delta. The proposal includes an underground tunnel to deliver water south of the delta.
FAIR Act

To amend title XVIII of the Social Security Act to require as a condition of satisfying the definition of an approved medical residency training program for purposes of payments under Medicare for costs related to graduate medical education for hospitals operating such a program to submit information to encourage more equitable treatment of osteopathic and allopathic candidates in the residency application and review process, and for other purposes. 1. Short title This Act may be cited as the Fair Access In Residency Act FAIR Act 2. Encouraging more equitable treatment of osteopathic and allopathic candidates in residency application and review process (a) In general Section 1886(h)(5)(A) of the Social Security Act ( 42 U.S.C. 1395ww(h)(5)(A) Such term shall not include a program operated by a hospital, with respect to a year (beginning with 2023), unless such hospital submits to the Secretary for such year— (i) the number of applicants for residency in such program who are from osteopathic medical schools and the number who are from allopathic medical schools; (ii) the number of such applicants who were accepted into such program from each of such types of medical school; and (iii) an affirmation that— (I) the hospital accepts applicants for such program from both osteopathic and allopathic medical schools; and (II) if an examination score is required for acceptance in such program, the Comprehensive Osteopathic Medical Licensing Examination of the United States (COMLEX–USA) and the United States Medical Licensing Examination (USMLE) are equally accepted. . (b) Publication The Secretary of Health and Human Services shall publish on a public website the information described in clauses (i) and (ii) of section 1886(h)(5)(A) of the Social Security Act, and the affirmation described in clause (iii) of such section, submitted by each approved medical residency training program for each year (beginning with 2023).

Summary: Fair Access In Residency Act or the FAIR Act This bill requires hospitals to certify that they accept residency applications from both osteopathic and allopathic medical schools and to disclose the number of applicants and acceptances from each type of program in order to receive graduate medical education payments under Medicare.
Protecting American Savers and Retirees Act

To amend the Inflation Reduction Act of 2022 to prevent the excise tax on repurchase of corporate stock from taking effect. 1. Short title This Act may be cited as the Protecting American Savers and Retirees Act 2. Repeal of excise tax on repurchase of corporate stock (a) In general The Inflation Reduction Act of 2022 ( Public Law 117–169 (b) Effective date The amendment made by this section shall take effect as if included in the Inflation Reduction Act of 2022.

Summary: Protecting American Savers and Retirees Act This bill repeals the 1% excise tax on the repurchase of corporate stock enacted by the Inflation Reduction Act of 2022.
Generic Animal Drug Advancement Act

To amend the Federal Food, Drug, and Cosmetic Act to make certain changes with respect to the approval of abbreviated applications for the approval of new animal drugs, and for other purposes. 1. Short title This Act may be cited as the Generic Animal Drug Advancement Act 2. Changes to process for approval of abbreviated applications for the approval of new animal drugs Section 512 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360b (1) in subsection (d)(4), in the matter preceding subparagraph (A), by striking section 512(b)(1) paragraph (1) or (2) of subsection (b) (2) in subsection (n)(1)(F)— (A) by striking or because the new animal drug because the new animal drug (B) by striking manufacturers; manufacturers, or because the new animal drug is not shown to be bioequivalent to all of the species for which the approved new animal drug is approved for use (3) by amending subsection (o) to read as follows: (o) For purposes of this section— (1) the term bioequivalent (A) demonstrating bioequivalence in at least one major species for which the approved new animal drug is approved for use; or (B) in the case that an approved new animal drug is not approved for use in any major species, demonstrating bioequivalence in at least one species for which the approved new animal drug is approved for use; and (2) the term patent .

Summary: Generic Animal Drug Advancement Act This bill allows for the approval and corresponding labeling of generic animal drugs that are bioequivalent to another approved drug with respect to at least one species, rather than with respect to all of the same species. (Animal drugs are drugs that are intended for animals other than humans (e.g., pets and livestock). Animal drugs must be approved by the Food and Drug Administration before they may be offered on the commercial market.)
SAFE for Patients Act

To establish a cause of action with respect to reproductive health services, and for other purposes. 1. Short title This Act may be cited as the Saving Abortion Facilities from Extremists for Patients Act SAFE for Patients Act 2. Cause of action with respect to reproductive health services (a) Cause of action Any person may bring a civil action against any person who— (1) intentionally damages or destroys the property of a facility that provides reproductive health services, or attempts to do so, because such facility provides reproductive health services; (2) by force or threat of force or by physical obstruction intentionally harasses, injures, intimidates, or interferes with a person because that person is providing or obtaining reproductive health services; or (3) knowingly engages in conduct that aids or abets the performance of an action described pursuant to paragraphs (1) or (2). (b) Award of damages If a claimant prevails on an action brought under subsection (a), the court shall award— (1) injunctive relief sufficient to prevent the defendant from further violation of subsection (a) or engaging in acts that aid or abet a violation of subsection (a); (2) statutory damages in an amount of not less than $10,000 per violation of subsection (a); and (3) costs and attorney’s fees. (c) Not a defense Notwithstanding any other law, the following shall not be a defense for a violation of subsection (a): (1) Ignorance or mistake of law. (2) A defendant’s belief that the requirements of this section are unconstitutional or were unconstitutional. (3) A defendant’s reliance on any court decision that has been overruled on appeal or by a subsequent court, even if that court decision had not been overruled when the defendant engaged in conduct that violates this section. (4) A defendant’s reliance on any State or Federal court decision that is not binding on the court in which the action has been brought. (5) Non-mutual issue preclusion or non-mutual claim preclusion. (d) Statute of limitations A person may bring an action under this section not later than the four years after the date on which the violation of subsection (a) occurred. (e) Reproductive health services defined In this section, the term reproductive health services

Summary: Saving Abortion Facilities from Extremists for Patients Act or the SAFE for Patients Act This bill establishes a civil action for damaging or destroying a reproductive health care facility or for harassing, injuring, or intimidating a person who provides or obtains reproductive health services.
Biologics Competition Act of 2022

To direct the Secretary of Health and Human Services to evaluate the extent to which the substitution of interchangeable biological products may be impeded by differences between the system for determining a biological product to be interchangeable and the system for assigning therapeutic equivalence ratings to drugs, and for other purposes. 1. Short title This Act may be cited as the Biologics Competition Act of 2022 2. Study on certain impediments to the substitution of interchangeable biological products Not later than 12 months after the date of enactment of this Act, the Secretary of Health and Human Services shall— (1) complete a study to evaluate the extent to which the substitution of interchangeable biological products licensed under section 351 of the Public Health Service Act ( 42 U.S.C. 262 42 U.S.C. 262(k)(4) 21 U.S.C. 355 (2) submit a report to the Congress on the results of the study under paragraph (1); and (3) update the list published under section 351(k)(9)(A) of the Public Health Service Act ( 42 U.S.C. 262(k)(9)(A) Purple Book (A) minimizing impediments to the substitution of interchangeable biological products; and (B) maintaining the distinct pathways by which biological products are licensed under section 351 of the Public Health Service Act ( 42 U.S.C. 262 21 U.S.C. 355

Summary: Biologics Competition Act of 2022 This bill requires the Food and Drug Administration (FDA) to evaluate (1) the differences between the requirements that apply to interchangeable biologics and the requirements that apply to therapeutically equivalent ratings for generic drugs, and (2) the effects of these differences on the approval of interchangeable biologics. The FDA must update the Purple Book with changes that better align the ways these requirements are communicated while still maintaining each distinct approval pathway. The Purple Book is an FDA publication that lists approved biological products, including biosimilars and interchangeable biologics. Interchangeable biologics are biologics that may be substituted for the original product without consulting the prescriber, similar to how generic drugs may be substituted for brand-name drugs based on therapeutic equivalence.
RIDE Act of 2021

To amend title 23, United States Code, to create a pilot program concerning drugged driving prevention, and for other purposes. 1. Short title This Act may be cited as the Reinforcing Impaired Driving Education Act of 2021 RIDE Act of 2021 2. Pilot program on drugged driving prevention Section 403 of title 23, United States Code, is amended by adding at the end the following: (k) Drugged driving prevention pilot program (1) In general Not later than 1 year after the date of enactment of this subsection, the Secretary of Transportation, acting through the Administrator of the National Highway Traffic Safety Administration, shall establish a pilot program to create, and study the effects of, a public marketing campaign to raise awareness on driving while under the influence of prescription and over-the-counter medications. (2) Consultation In implementing the pilot program, the Secretary may consult with pharmacies, pharmaceutical companies, and governmental and nongovernmental organizations. (3) Locations The Secretary shall implement the pilot program in States or territories that are most affected by the opioid epidemic. (4) Sunset The pilot program shall terminate on the date that is 2 years after the date on which the pilot program is established. (5) Report Not later than 1 year after the date of termination of the pilot program, the Secretary shall submit to Congress a report on the results of the study of the effects of the public marketing campaign. .

Summary: Reinforcing Impaired Driving Education Act of 2021 or the RIDE Act of 2021 This bill requires the National Highway Traffic Safety Administration to establish a two-year pilot program to create and study the effects of a public marketing campaign to raise awareness on driving while under the influence of prescription and over-the-counter medications. The program shall be implemented in states or territories that are most affected by the opioid epidemic.
Higher Education Accountability Tax Act

To amend the Internal Revenue Code of 1986 to modify the excise tax on investment income of private colleges and universities. 1. Short title This Act may be cited as the Higher Education Accountability Tax Act 2. Modification of excise tax on investment income of private colleges and universities (a) Increase in rate of tax Section 4968(a) 1.4 percent 10 percent (b) Additional increase in rate of tax for institutions with increases in net price (1) In general Section 4968(a) of such Code, as amended by subsection (a), is amended by inserting (20 percent in the case of a net-price-increase institution) 10 percent (2) Net-price-increase institution Section 4968(b) of such Code is amended by redesignating paragraph (2) as paragraph (3) and by inserting after paragraph (1) the following new paragraph: (2) Net-price-increase institution The term net-price-increase institution net price 20 U.S.C. 1015a(a)(3) . (c) Expansion of institutions subject to tax Section 4968(b)(1)(D) of such Code is amended by striking $500,000 $250,000 (d) Effective date The amendments made by this section shall apply to taxable years beginning after December 31, 2022.

Summary: Higher Education Accountability Tax Act This bill increases from 1.4% to 10% the rate of the excise tax on the net investment income of applicable educational institutions (i.e., certain private colleges and universities). It further increases to 20% the rate of such tax on net-price-increase institutions (i.e., educational institutions whose net price increased at a rate exceeding the rate of increase in the Consumer Price Index during a specified three-year period). The bill also modifies the definition of applicable educational institution to lower the per student threshold in that definition from $500,000 to $250,000 (thus making more such institutions subject to the excise tax).
Medicare Opioid Use Disorder Outreach Act

To direct the Secretary of Health and Human Services to provide outreach and reporting on opioid use disorder treatment services furnished by opioid treatment programs under the Medicare program. 1. Short title This Act may be cited as the Medicare Opioid Use Disorder Outreach Act 2. Outreach and reporting on opioid use disorder treatment services furnished by opioid treatment programs (a) Outreach (1) Provider outreach The Secretary of Health and Human Services (in this section referred to as the Secretary 42 U.S.C. 1395 et seq. 42 U.S.C. 1395x(jjj) (2) Beneficiary outreach The Secretary shall conduct outreach to Medicare beneficiaries with respect to opioid use disorder treatment services furnished by an opioid treatment program (as defined in section 1861(jjj) of the Social Security Act ( 42 U.S.C. 1395x(jjj) (b) Reports to congress (1) Outreach Not later than 1 year after the date of the completion of the education initiatives described in subsection (a), the Secretary shall submit to the Committee on Ways and Means and the Committee on Energy and Commerce of the House of Representatives and the Committee on Finance of the Senate a report on the outreach conducted under such subsection. Such report shall include a description of the methods used for such outreach. (2) Utilization rates Not later than 18 months after the date of the completion of the education initiatives described in subsection (a), and two years thereafter, the Secretary shall submit to the Committee on Ways and Means and the Committee on Energy and Commerce of the House of Representatives and the Committee on Finance of the Senate a report on the number of Medicare beneficiaries who, during the preceding year, were furnished opioid use disorder treatment services by an opioid treatment program (as defined in section 1861(jjj) of the Social Security Act ( 42 U.S.C. 1395x(jjj) 42 U.S.C. 1395 et seq.

Summary: Medicare Opioid Use Disorder Outreach Act This bill requires the Centers for Medicare & Medicaid Services to (1) conduct outreach to providers and beneficiaries about the availability of opioid use disorder treatment services through opioid treatment programs under Medicare, and (2) report on the utilization of such services.
Promoting Clarity in Mental Health and Substance Use Disorder Treatment Act

To amend the Public Health Service Act, Internal Revenue Code of 1986, and Employee Retirement Income Security Act of 1974 to ensure mental health and substance use disorder benefits are defined pursuant to external benchmarks based on nationally recognized standards. 1. Short title This Act may be cited as the Promoting Clarity in Mental Health and Substance Use Disorder Treatment Act 2. Ensuring mental health and substance use disorder benefits are defined pursuant to external benchmarks based on nationally recognized standards (a) PHSA Section 2726(e) of the Public Health Service Act ( 42 U.S.C. 300gg–26(e) (1) in paragraph (4), by adding at the end the following new sentence: Any definition of the term mental health condition (2) in paragraph (5), by adding at the end the following new sentence: Any definition of the term substance use disorder (b) IRC Section 9812(e) (1) in paragraph (4), by adding at the end the following new sentence: Any definition of the term mental health condition (2) in paragraph (5), by adding at the end the following new sentence: Any definition of the term substance use disorder (c) ERISA Section 712(e) of the Employee Retirement Income Security Act of 1974 ( 29 U.S.C. 1185a(e) (1) in paragraph (4), by adding at the end the following new sentence: Any definition of the term mental health condition (2) in paragraph (5), by adding at the end the following new sentence: Any definition of the term substance use disorder (d) Implementation The Secretaries of Labor, Health and Human Services, and the Treasury may implement the provisions of, including the amendments made by, this section through interim final rule, sub-regulatory guidance, program instruction, or otherwise. (e) Effective date The amendments made by this section shall apply with respect to plan years beginning on or after the date that is 6 months after the date of the enactment of this Act.

Summary: Promoting Clarity in Mental Health and Substance Use Disorder Treatment Act This bill requires health insurance plans to define their coverage of mental health conditions and substance use disorder based on specified external benchmarks.